Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
RESEARCH TOOLSreports
Total Valuation
Ascentage Pharma Group International Unsponsored ADR has a market cap or net worth of $4.25B. The enterprise value is $3.37B.
Market Cap$4.25B
Enterprise Value$3.37B
Share Statistics
Ascentage Pharma Group International Unsponsored ADR has 92,963,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding92,963,370
Owned by Insiders―
Owned by Institutions0.23%
Financial Efficiency
Ascentage Pharma Group International Unsponsored ADR’s return on equity (ROE) is -1.53 and return on invested capital (ROIC) is -17.02%.
Return on Equity (ROE)-1.53
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-17.02%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee1.73M
Profits Per Employee-697.10K
Employee Count567
Asset Turnover0.37
Inventory Turnover4.41
Valuation Ratios
The current PE Ratio of Ascentage Pharma Group International Unsponsored ADR is ―. Ascentage Pharma Group International Unsponsored ADR’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value36.26
Price to FCF―
Price to Operating Cash Flow-229.68
PEG Ratio―
Income Statement
In the last 12 months, Ascentage Pharma Group International Unsponsored ADR had revenue of 980.65M and earned -405.43M in profits. Earnings per share was -0.75.
Revenue980.65M
Gross Profit951.57M
Operating Income-369.73M
Pretax Income-395.25M
Net Income-405.43M
EBITDA-237.63M
Earnings Per Share (EPS)-0.75
Cash Flow
In the last 12 months, operating cash flow was -9.06M and capital expenditures -301.31K, giving a free cash flow of -9.36M billion.
Operating Cash Flow-9.06M
Free Cash Flow-9.36M
Free Cash Flow per Share-0.10
Dividends & Yields
Ascentage Pharma Group International Unsponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change177.68%
50-Day Moving Average39.50
200-Day Moving Average―
Relative Strength Index (RSI)68.79
Average Volume (3m)8.53K
Important Dates
Ascentage Pharma Group International Unsponsored ADR upcoming earnings date is Apr 1, 2026, TBA (Confirmed).
Last Earnings DateAug 20, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International Unsponsored ADR as a current ratio of 1.26, with Debt / Equity ratio of 631.54%
Current Ratio1.26
Quick Ratio1.26
Debt to Market Cap0.17
Net Debt to EBITDA-1.82
Interest Coverage Ratio-5.74
Taxes
In the past 12 months, Ascentage Pharma Group International Unsponsored ADR has paid 10.43M in taxes.
Income Tax10.43M
Effective Tax Rate-0.03
Enterprise Valuation
Ascentage Pharma Group International Unsponsored ADR EV to EBITDA ratio is -42.13, with an EV/FCF ratio of -73.80.
EV to Sales10.21
EV to EBITDA-42.13
EV to Free Cash Flow-73.80
EV to Operating Cash Flow-89.90
Balance Sheet
Ascentage Pharma Group International Unsponsored ADR has $50.58M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$50.58M billion.
Cash & Marketable Securities$50.58M
Total Debt$0.00
Net Cash-$50.58M
Net Cash Per Share-$0.54
Tangible Book Value Per Share$2.30
Margins
Gross margin is 97.03%, with operating margin of -37.70%, and net profit margin of -41.34%.
Gross Margin97.03%
Operating Margin-37.70%
Pretax Margin-40.31%
Net Profit Margin-41.34%
EBITDA Margin-24.23%
EBIT Margin-33.73%
Analyst Forecast
The average price target for Ascentage Pharma Group International Unsponsored ADR is $38.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$38.00
Price Target Upside-20.34% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-56.78%
EPS Growth Forecast-191.46%